WHOOP is the first device to be used in COVID-19 phase 3 vaccine trials

The Whoop4Humanity initiative ensures that volunteers who now enroll in DNAEC clinical trials in Abu Dhabi and the Al Qarain Center in Sharjah, adding up to those coming for the time being, can increase their participation on the trails by using the new portable devices that allow them to check their daily central rate, breathing rate, central frequency variability Organize their sleep performance Etc.

Commenting on the new partnership, Ashish Koshy, CEO of G42 Healthcare, said, “As a virtual company, this new partnership is a logical extension of the AI responses and highly complex supercomputers we already use in the testing process. Invited to have interaction in the evolved generation through WHOOP so that their individual volunteers delight and contribute to the complex studies involved in these complicated trials.

Leave a Comment

Your email address will not be published. Required fields are marked *